Stauungsherzinsuffizienz (Kompensiert, Investigatives Adjuvans)

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?

Not FDA-cleared for heart failure. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for CHF is highly investigational.

Welche Evidenz existiert?

Tier C (highly investigational). Only anecdotal case series report subjective symptom improvement; there are no randomized controlled trials and no mortality or hospitalization data. Evidence-based therapy per ACC/AHA/HFSA 2022 guidelines (Guideline-Directed Medical Therapy) includes ARNI (sacubitril/valsartan) or ACE inhibitor / ARB, beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor — these reduce all-cause mortality and hospitalization. Many HF patients require anticoagulation or antiplatelet therapy, which contraindicate leech application.

Hauptrisiken

• Bleeding from bite sites for 6 to 24 hours after detachment
• Worsening anemia in patients with cumulative blood loss across sessions
• Hypotension or orthostasis, especially on aggressive diuretic regimens
• Light-headedness, fainting, or fall risk
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva (uncommon)
• Delay or replacement of GDMT with risk of decompensation, hospitalization, or death

Wer dies nicht in Betracht ziehen sollte

• Patients with NYHA III or IV decompensated heart failure
• Patients on any anticoagulant or dual antiplatelet therapy
• Patients within 3 months of MI, unstable angina, or revascularization
• Patients with symptomatic orthostatic hypotension or recurrent falls
• Patients with severe valvular disease awaiting surgical intervention
• Patients with severe anemia (Hb under 10 g/dL), active infection, or immunosuppression
• Pregnant patients

Was Sie Ihren Kliniker fragen sollten

• Am I on full guideline-directed medical therapy (ARNI / ACE-ARB, beta-blocker, MRA, SGLT2 inhibitor)?
• What is my left-ventricular ejection fraction, NYHA class, and BNP / NT-proBNP trend?
• Am I a candidate for additional therapies (CRT, ICD, mitral valve repair, transplant, LVAD)?
• What is my cardiology team's opinion on complementary therapy in my specific case?
• Will my anticoagulant / antiplatelet status be reviewed before any leech application?
• What is the practitioner's experience and Aeromonas-prevention plan?
• How will diuretic dosing and weights be monitored during treatment?

Wann dringende medizinische Versorgung suchen

• Shortness of breath at rest, inability to lie flat, or new orthopnea
• Weight gain over 2 kg / 4 lbs in 2 days, new or worsening leg swelling
• Chest pain, pressure, or palpitations (call 911 if severe)
• Light-headedness, fainting, or a fall
• Bleeding from a bite site lasting more than 24 to 48 hours
• Fever above 38.0 C / 100.4 F, spreading redness, or pus
• Hives, throat tightness, or breathing difficulty